Sidley is advising BDT & MSD Partners in connection with their AU$1.6 billion investment in DBG Health, a leading Australian beauty and pharmaceutical company. This strategic investment values DBG Health at approximately AU$7 billion and includes up to AU$1 billion of additional funding for future acquisitions, making this one of the largest private founder-led transactions in Australian corporate history.
The Sidley team is led by David Perkins and Rob Garritano (M&A and Private Equity), and includes Louis Jennings and Adi Milstein (M&A and Private Equity); Noam Waltuch, Rachel Kleinberg, and Andy Lau (Tax); Diane McEnroe, Deeona Gaskin, Susan Stolzer, and Kelly Cho (Food, Drug and Medical Device); Chad Ehrenkranz, George Maliha M.D., and Jenna Hoskison (Healthcare); and Vadim Brusser and Mary Marks (Antitrust and Competition).